Rifaximin for Pertuzumab-Related GI Toxicities

by Aixa E. Soyano, Gina Reynolds, Alvaro Moreno-Aspitia, Saranya Chumsri
Published 2017-08-01

Next generation of immune checkpoint therapy in cancer: new developments and challenges

by Julian A. Marin-Acevedo, Bhagirathbhai Dholaria, Aixa E. Soyano, Keith L. Knutson, Saranya Chumsri, Yanyan Lou
Published 2018-03-01

Asymptomatic coronavirus disease 2019 mimicking metastatic breast cancer on positron emission tomography/computed tomography imaging

by Tanmayi S. Pai, MD, Carlos Rojas, MD, Martha C. Wasserman, MD, Ephraim E. Parent, MD, PhD, Lauren Cornell, MD, Saranya Chumsri, MD
Published 2021-08-01

Peripheral blood biomarkers correlate with outcomes in advanced non-small cell lung Cancer patients treated with anti-PD-1 antibodies

by Aixa E. Soyano, Bhagirathbhai Dholaria, Julian A. Marin-Acevedo, Nancy Diehl, David Hodge, Yan Luo, Rami Manochakian, Saranya Chumsri, Alex Adjei, Keith L. Knutson, Yanyan Lou
Published 2018-11-01

Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: analysis from the ALTTO (BIG 2-06) trial

by Francesca Poggio, Lucia Del Mastro, Florentine S Hilbers, Saranya Chumsri, Noam F Pondé, Dominique Agbor-Tarh, Otto Metzger-Filho, Larissa A Korde, Olena Werner, Volker Moebus, Alvaro Moreno-Aspitia, Martine J Piccart
Published 2020-12-01